Aromasin Dragon Pharma


Aromasin (chemical name: Exemestane) is a drug developed by Pharmacia and Upjohn in the late 1990s. It belongs to a class of drugs known as aromatase inhibitors, which are used to treat breast cancer in postmenopausal women.

Aromasin works by inhibiting the enzyme aromatase, which is responsible for converting testosterone into estrogen. By reducing the amount of estrogen produced by the body, it helps to reduce tumors that rely on estrogen for growth and division. This makes it effective at treating hormone-receptor-positive breast cancer – breast cancers that require hormones like estrogen to grow and spread throughout the body.

In addition to being prescribed as part of standard treatments for certain types of breast cancer, Aromasin has also been used off-label in athletes and bodybuilders who use anabolic steroids or testosterone boosters as part of their training regimen. Since these drugs increase levels of natural testosterone in the body, they also result in increased production of estrogen due to its conversion from testosterone via aromatase; this can cause unwanted side effects such as gynecomastia (breast tissue development).

To avoid these side effects without sacrificing performance gains from steroid use, many athletes use Aromasin alongside their regular cycle or booster cycle as an anti-estrogenic agent – essentially preventing any excess levels buildup that could lead to gynaecomastia later on down the line.

Dragon Pharma’s version of Aromasin is often chosen over other brands because it’s made with higher quality materials than unlicensed competitors – ensuring users get exactly what they paid for when ordering online or through channels other than traditional pharmacies or medical outlets.